Allianz Asset Management
ELOS

Allianz Asset Management’s Syneron Medical Ltd ELOS Stock Holding History

Allianz Asset Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50,000
Closed -$548K – 2755
2017
Q2 		$548K Buy
+50,000
New +$548K ﹤0.01% 2396

Other funds holding ELOS

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
LAM
Lapides Asset Management Greenwich, Connecticut $153M AUM 9.03% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $33K AUM 23.36% 1-Year Est. Return

Allianz Asset Management's ELOS Position: Q3 2017 in Review

Allianz Asset Management sold out of Syneron Medical Ltd (ELOS) in Q3 2017, closing a stake of 50,000 shares — an estimated $548K sold.

Allianz Asset Management first reported a position in ELOS in Q2 2017 and held it in 1 quarter. The position peaked at $548K in Q2 2017. 4 funds tracked by Wall St. Rank hold ELOS as of Q3 2017.

  • Allianz Asset Management reported no remaining Syneron Medical Ltd position as of Q3 2017 after selling out during the quarter.
  • Allianz Asset Management sold 50,000 Syneron Medical Ltd shares in Q3 2017, an estimated $548K.
  • Allianz Asset Management first reported a position in Syneron Medical Ltd in Q2 2017 and held it in 1 quarter.
  • Allianz Asset Management's Syneron Medical Ltd position peaked at $548K in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q3 2017.

Based on Allianz Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.